TGA Approval

SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial-single dose (406730)

ARTG ID

406730

ARTG Name

SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial-single dose

Sponsor

Moderna Australia Pty Ltd

ARTG Date

June 8, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Moderna Australia Pty Ltd

Sponsor Item Name

MODERNA AUSTRALIA PTY LTD

Active Ingredients

Ingredient Name

davesomeran

Ingredient Name

elasomeran

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial-single dose (406730) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial-single dose (406730)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal